**US63633D1046 - REIT - After market: 49.36 0 (0%)**

Taking everything into account, **NHI** scores **4** out of 10 in our fundamental rating. **NHI** was compared to 210 industry peers in the **Equity Real Estate Investment Trusts (REITs)** industry. **NHI** scores bad on very profitability, while its financial health is fine. Not spectacular, but in line with the averages. **NHI** is quite expensive at the moment. It does show a decent growth rate.

ROA (2.65%) VS Industry: 39% outperformed.

0.03

26.09

ROE (5.23%) VS Industry: 34% outperformed.

0.08

135.39

Profit Margin (23.87%) VS Industry: 42% outperformed.

0.08

881.04

With a **Forward Price/Earnings Ratio** of **17.27**, **NHI** is valued rather expensively.

With a price book ratio of **1.69**, **NHI** is valued correctly.

When comparing the **Enterprise Value to EBITDA** ratio of **NHI** to the average industry ratio of 15.65, **NHI** is valued in line with its industry peers.

The **Price/Earnings Ratio** is **33.35**, which means the current valuation is very expensive for **NHI**.

Compared to an average industry price book ratio of 1.09, **NHI** is valued more expensive than its industry peers.

Price/Earnings (33.35) VS Industry: 30% outperformed.

510.11

0.67

Price/Book (1.69) VS Industry: 33% outperformed.

46.45

0.08

Enterprise Value/ EBITDA (15.05) VS Industry: 54% outperformed.

128.53

2.05

The EPS growth is accelerating: in the next 5 years the growth will be better than in the last years.

When comparing the Revenue growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.

Looking at the last year, **NHI** shows a decrease in **Revenue**. The Revenue has decreased by **-6.87%** in the last year.

Past | Future | ||||||
---|---|---|---|---|---|---|---|

5Y | 3Y | 1Y | 1Y | 2Y | 3Y | 5Y | |

EPS | -17.49% | -26.65% | -39.34% | 93.09% | 43.67% | N/A | N/A |

Revenue | -0.04% | -4.37% | -6.87% | 13.78% | 10.71% | N/A | N/A |

The Quick Ratio of **NHI** is much better than the industry average of **0.66**.

The Altman-Z score of **NHI** is much better than the industry average of **0.73**.

The Debt to Equity ratio of **NHI** is in line with the industry averages.

Debt/Equity (0.9) VS Industry: 57% outperformed.

21.53

0.00

Quick Ratio (1.54) VS Industry: 77% outperformed.

0.00

90.22

Current Ratio (1.54) VS Industry: 75% outperformed.

0.00

90.22

Altman-Z (1.15) VS Industry: 67% outperformed.

-0.94

37.03

With a **Yearly Dividend Yield** of **6.41%**, **NHI** is a good candidate for dividend investing.

Compared to an average industry **Dividend Yield** of **4.94**, **NHI** pays a bit more dividend than its industry peers.

Dividend Yield (6.41%) VS Industry: 71% outperformed.

0.27

13.72

NYSE:NHI (3/24/2023, 7:00:00 PM)**+1.11 (+2.3%) **

Chartmill FA Rating

GICS SectorReal Estate

GICS IndustryGroupReal Estate

GICS IndustryEquity Real Estate Investment Trusts (REITs)

Earnings (Last)02-21 2023-02-21/amc

Earnings (Next)05-08 2023-05-08/amc

Inst Owners62.54%

Inst Owner Change-2.85%

Ins Owners0.58%

Ins Owner Change0%

Market Cap2.14B

Analysts70

Price Target59.98 (21.52%)

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 6.41% |

Dividend Growth(5Y)0.46%

DP243.62%

Div Incr YearsN/A

Div Non Decr YearsN/A

Ex-Date03-30 2023-03-30 (0.9)

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-47.47%

Min EPS beat(2)-95.23%

Max EPS beat(2)0.3%

EPS beat(4)1

Avg EPS beat(4)-50.39%

Min EPS beat(4)-95.23%

Max EPS beat(4)0.3%

Revenue beat(2)1

Avg Revenue beat(2)-3.95%

Min Revenue beat(2)-9.03%

Max Revenue beat(2)1.13%

Revenue beat(4)1

Avg Revenue beat(4)-7.92%

Min Revenue beat(4)-20.44%

Max Revenue beat(4)1.13%

PT rev (1m)-3.34%

PT rev (3m)-4.39%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)-4.23%

EPS NY rev (3m)-4.23%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)-0.93%

Revenue NY rev (3m)-0.93%

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 33.35 | ||

Fwd PE | 17.27 | ||

P/S | 7.7 | ||

P/FCF | 11.97 | ||

P/OCF | 11.56 | ||

P/B | 1.69 | ||

P/tB | 1.69 | ||

EV/EBITDA | 15.05 |

EPS(TTM)1.48

EY3%

EPS(NY)2.86

Fwd EY5.79%

FCF(TTM)4.12

FCFY8.36%

OCF(TTM)4.27

OCFY8.65%

SpS6.41

BVpS29.28

TBVpS29.28

PEG (NY)0.36

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 2.65% | ||

ROE | 5.23% | ||

ROIC | 4.63% | ||

ROICexc | 4.67% | ||

ROICexgc | 4.69% | ||

OM | 51.46% | ||

PM | 23.87% | ||

GM | 86.35% |

ROICexgc(3y)5.36%

ROICexcg growth 3Y-7.49%

ROICexcg growth 5Y-5.92%

ROICexc(3y)5.33%

ROICexc growth 3Y-7.44%

ROICexc growth 5Y-5.94%

OM growth 3Y-9.38%

OM growth 5Y-6.23%

PM growth 3Y-22.08%

PM growth 5Y-16.04%

GM growth 3Y-4.19%

GM growth 5YN/A

F-Score5

Asset Turnover0.11

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.9 | ||

Debt/FCF | 6.41 | ||

Debt/EBITDA | 5.36 | ||

Cap/Depr | 8.98% | ||

Profit Quality | 269.53% | ||

Current Ratio | 1.54 | ||

Quick Ratio | 1.54 | ||

Altman-Z | 1.15 |

F-Score5

WACC6.71%

ROIC/WACC0.7

Cap/Depr(3y)63.45%

Cap/Depr(5y)132.13%

Profit Quality(3y)162.05%

Profit Quality(5y)109.81%

Growth

EPS 1Y-39.34%

EPS 3Y-26.65%

EPS 5Y-17.49%

EPS growth Q2Q-71.43%

EPS Next Y93.09%

EPS Next 2Y43.67%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue growth 1Y-6.87%

Revenue growth 3Y-4.37%

Revenue growth 5Y-0.04%

Revenue growth Q2Q1.44%

Revenue Next Year13.78%

Revenue Next 2Y10.71%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-23.09%

EBIT growth 3Y-13.34%

EBIT growth 5Y-6.26%

EBIT Next Year92.1%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y9.1%

FCF growth 3Y101.73%

FCF growth 5Y34.34%

OCF growth 1Y-12.1%

OCF growth 3Y-8.38%

OCF growth 5Y-1.32%

*Find stocks with similar Fundamental rating on the USA*

*Find the competitors with the best fundamentals on the USA*

*Find the competitors with the best valuation on the USA*

*Find the competitors with the best dividend on the USA*